Efficient Expression of Antibody Fragments with the Brevibacillus Expression System.
- Published in:
- Antibodies (2073-4468), 2014, v. 3, n. 2, p. 242, doi. 10.3390/antib3020242
- By:
- Publication type:
- Article
Works matching IS 20734468 AND DT 2014 AND VI 3 AND IP 2
Results: 6
1
2
Refolding Technologies for Antibody Fragments.
- Published in:
- Antibodies (2073-4468), 2014, v. 3, n. 2, p. 232, doi. 10.3390/antib3020232
- By:
- Publication type:
- Article
3
Kinetic Characterization of a Panel of High-Affinity Monoclonal Antibodies Targeting Ricin and Recombinant Re-Formatting for Biosensor Applications.
- Published in:
- Antibodies (2073-4468), 2014, v. 3, n. 2, p. 215, doi. 10.3390/antib3020215
- By:
- Publication type:
- Article
4
Engineered Bovine Antibodies in the Development of Novel Therapeutics, Immunomodulators and Vaccines.
- Published in:
- Antibodies (2073-4468), 2014, v. 3, n. 2, p. 205, doi. 10.3390/antib3020205
- By:
- Publication type:
- Article
5
Role of B Cells in Breaking and Maintaining Tolerance to Clotting Factor VIII in Congenital and Acquired Hemophilia A.
- Published in:
- Antibodies (2073-4468), 2014, v. 3, n. 2, p. 192, doi. 10.3390/antib3020192
- By:
- Publication type:
- Article
6
The Biotechnological Applications of Recombinant Single-Domain Antibodies are Optimized by the C-Terminal Fusion to the EPEA Sequence (C Tag).
- Published in:
- Antibodies (2073-4468), 2014, v. 3, n. 2, p. 182, doi. 10.3390/antib3020182
- By:
- Publication type:
- Article